CAMBRIDGE, Mass., Apr 12, 2012 (BUSINESS WIRE) --Verastem, Inc., (NASDAQ: VSTM) a biopharmaceutical company focused on
discovering and developing drugs to treat breast and other cancers by
targeting cancer stem cells, announced that the Company will present at
the BioCentury Future Leaders in the Biotech Industry conference on
April 20, 2012, in New York City.
The Verastem presentation will be at 3:00pm ET on Friday, April 20,
2012, in room 302/303 at the Millennium Hotel in New York, NY. Following
the presentation there will be a breakout session from 3:30 - 4:00pm ET,
in room 301.
About Verastem, Inc.
Verastem, Inc. (NASDAQ: VSTM) is a biopharmaceutical company focused on
discovering and developing drugs to treat breast and other cancers by
targeting cancer stem cells. Cancer stem cells are an underlying cause
of tumor recurrence and metastasis. For more information please visit www.verastem.com.
Forward-looking statements:
Any statements in this press release about future expectations, plans
and prospects for the Company constitute forward-looking statements
within the meaning of The Private Securities Litigation Reform Act of
1995. Actual results may differ materially from those indicated by such
forward-looking statements. The Company anticipates that subsequent
events and developments will cause the Company's views to change.
However, while the Company may elect to update these forward-looking
statements at some point in the future, the Company specifically
disclaims any obligation to do so.
SOURCE: Verastem, Inc.
Investor contact:
Verastem, Inc.
Brian Sullivan,
617-252-9314
bsullivan@verastem.com
or
Media
contact:
For Verastem, Inc.
Kari Watson, 781-235-3060
kwatson@macbiocom.com
